Form D Explorer

Form C/A — Genomic Expression, Inc.

0001665160-24-001406 · filed 2024-10-16 · via StartEngine Capital, LLC

Offering

Target: $15,000
Maximum: $1,235,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: Genomic Expression, Inc.
CIK: 1611868
Entity: Corporation
Jurisdiction: DE
Address: 100 CUMMINGS CENTER, SUITE 451C,
BEVERLY, MA 01915
Phone: —

Most recent fiscal year financials

Total assets

$1,024,831

Cash

—

Short-term debt

$288,027

Long-term debt

$472,665

Revenues

$222,724

COGS

—

Taxes paid

—

Net income

$-274,187

View original on SEC EDGAR.